Changes to U.S. vaccine policy under RFK Jr. challenged in court
Source: SeekingAlpha
2026-02-14 11:20:40 ET
More on Pfizer, Moderna, etc.
- Moderna, Inc. (MRNA) Q4 2025 Earnings Call Transcript
- Moderna, Inc. 2025 Q4 - Results - Earnings Call Presentation
- Pfizer: A Great Opportunity Post Earnings
- Earnings Scorecard: Healthcare sector shows strong top-line pulse
- Moderna outlines up to 10% revenue growth for 2026 amid international expansion and cost discipline
Read the full article on Seeking Alpha
For further details see:
Changes to U.S. vaccine policy under RFK Jr. challenged in court
BioNTech SE
NASDAQ: BNTX
BNTX Trading
1.5% G/L:
$109.68 Last:
177,864 Volume:
$109 Open:
BNTX Latest News
February 25, 2026 09:00:00 am
Immuno-Oncology Investments Accelerate as Pipeline Catalysts Multiply in 2026
February 24, 2026 06:45:00 am
BioNTech to Report Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on March 10, 2026
January 28, 2026 09:15:00 am
Late-Stage Breakthroughs: How 2026's Top Clinical Platforms Are Redefining Cancer Treatment
January 28, 2026 08:00:00 am
BioNTech Announces Appointment of Kylie Jimenez to Management Board as Chief People Officer
BNTX Stock Data
$26,377,590,776
95,508,380
N/A
104
N/A
Biotechnology & Life Sciences
Healthcare
DE
Mainz
